BFM
GILD icon

Boothbay Fund Management’s Gilead Sciences GILD Stock Holding History

Boothbay Fund Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,700
Closed -$228K – 2152
2022
Q3 		$228K Buy
+3,700
New +$233K 0.01% 1726
2022
Q2 		– Sell
-28,400
Closed -$1.69M – 2401
2022
Q1 		$1.69M Buy
+28,400
New +$1.82M 0.04% 647
2016
Q4 		– Sell
-6,400
Closed -$506K – 826
2016
Q3 		$506K Buy
+6,400
New +$520K 0.11% 211

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Boothbay Fund Management's GILD Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Gilead Sciences (GILD) in Q1 2026: 3,321 shares worth $463K. The stake represents 0.01% of the portfolio and ranks #1395 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in GILD as recently as Q3 2025.

Boothbay Fund Management first reported a position in GILD in Q2 2015 and has held it in 21 quarters since. The position peaked at $12.2M in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Boothbay Fund Management held 3,321 shares of Gilead Sciences worth $463K as of Q1 2026.
  • Gilead Sciences was a new Boothbay Fund Management position in Q1 2026.
  • Gilead Sciences made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1395 holding.
  • Boothbay Fund Management first reported a position in Gilead Sciences in Q2 2015 and has held it in 21 quarters since.
  • Boothbay Fund Management's Gilead Sciences position peaked at $12.2M in Q1 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.